Table 4.
Bone Metabolism Parameters Measured Before and 4 Weeks After PTX in Group III (n = 4)
| Pre‐PTX | Post‐PTX (4 weeks) | p Value | Power (%) | Normal values | |
|---|---|---|---|---|---|
| Intact PTH (pg/mL) | 961.5 ± 288.2 | 24.5 ± 15.7 | 0.125 | 98.5 | 10.0–65.0 |
| TRACP (U/L) | 24.2 ± 9.2 | 9.9 ± 1.9 | 0.125 | 66.8 | 5.5–17.2 |
| DPD (pmol/mL) | 26.8 ± 7.1 | 6.3 ± 1.4 | 0.125 | 73 | Unknown |
| PICP (ng/mL) | 300.3 ± 69.8 | 378.0 ± 104.0 | 0.125 | 30.2 | 30.0–182.0 |
| Total ALP (U/L) | 394.8 ± 106.6 | 461.8 ± 123.4 | 0.375 | 10.2 | 85.0–255.0 |
| Ca (mg/dL) | 9.9 ± 0.4 | 9.6 ± 1.1 | 0.5 | 8.4 | 8.4–10.4 |
| P (mg/dL) | 5.7 ± 0.8 | 2.8 ± 0.6 | 0.125 | 98.6 | 2.5–4.5 |
| 1.25 (OH)2D3 (pg/mL) | (−) | 5.3 ± 2.2 | (−) | (−) | 20.0–60.0 |
Plasma 1.25 (OH)2D3 levels were measured 1 week after PTX in group III.
PTX = Total parathyroidectomy; TRACP = tartrate‐resistant acid phosphatase; DPD = deoxypyridinoline; PICP = carboxy‐terminal propeptide of human type I procollagen; ALP = alkaline phosphatase.